King Charles III undergoes prostate surgery

The UK's sovereign will undergo a routinely scheduled operation to fix his enlarged prostate

by Lorenzo Ciotti
King Charles III undergoes prostate surgery
© WPA Pool / Team Getty Images Entertainment

After the news of Kate Middleton's hospitalization for abdominal surgery, Buckingham Palace, in a note, announced that King Charles III will undergo surgery for benign prostatic hypertrophy next week and his public commitments have been cancelled.

The press release from Buckingham Palace explained: "Like thousands of men every year, the King has been examined for an enlarged prostate. What His Majesty is suffering from is benign and the King will go to hospital next week for a corrective procedure."

King Charles III
King Charles III© Dan Kitwood / Staff Getty Images Entertainment

What is benign prostatic hypertrophy

Benign prostatic hyperplasia is a condition characterized by the increase in volume of the prostate gland and is not a malignant neoplasm. In fact, the increase in volume is not due to hypertrophy, but to a hyperplasia of the parenchymal and stromal component of the gland

It generally begins with the development of microscopic nodules made up mainly of stromal and parenchymal elements, which over the years, increasing in number and size, compress and distort the prostatic urethra producing an obstruction that hinders the flow of urine. The degree of significant symptoms of the disease varies considerably depending on the patient's lifestyle.

Men who lead a Western-style lifestyle have a higher incidence of BPH symptoms than those who lead a traditional and more rural life. This is confirmed by research conducted in China, which demonstrates how men who live in rural areas have lower frequencies of the pathology, while those who live in large cities, in the same nation, show a much higher incidence, although still much lower than men who live in the west.

The clinical manifestations are not correlated with the size of the gland: a small prostate can cause much more serious obstructive symptoms than a larger prostate. The symptomatology in fact derives from the sum of two components.

The static one, determined by the mass of the gland, and the dynamic one, due to the tone of the smooth muscles of the bladder neck, the prostate and its capsule. After the age of 50, an annual urological examination is recommended. In some patients, hyperplastic evolution of the prostate tissue can begin as early as 30 years of age. Approximately 50% of men over the age of 60 show signs of BPH; the percentage reaches 90% in patients aged 85 years or older.